Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19565858 | 0.79 | — | — | |
| SCHEMBL19565866 | 0.79 | — | — | |
| SCHEMBL19548829 | 0.74 | — | — | |
| SCHEMBL19548904 | 0.74 | — | — | |
| SCHEMBL7990371 | 0.69 | — | — | |
| SCHEMBL20049585 | 0.67 | — | — | |
| SCHEMBL7980897 | 0.67 | ALDH1A1 (0.31) | ALDH1A1ALOX15 | |
| SCHEMBL18922082 | 0.67 | — | — | |
| SCHEMBL2068452 | 0.67 | — | — | |
| SCHEMBL14754546 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101293881-A | Method for preparing dioxidized 4-vinyl cyclohexene | UNIV EAST CHINA NORMAL (CN) | 2008-10-29 | — | — | CN | disclosed |
| US-6906220-B2 | Process to produce 4-(2-sulfoethyl) cyclohexane, 1,2-diol sodium salt from 4-vinylcyclohexane-1,2-diol | Invista North America S.àr.l. (US) | 2005-06-14 | — | — | US | disclosed |
| WO-2004085355-A1 | A PROCESS FOR HYDROLYZING WATER-INSOLUBLE EPOXIDES | INVISTA TECHNOLOGIES S.À.R.L. (US) | 2004-10-07 | — | — | WO | disclosed |
| US-20040192971-A1 | Process to produce 4-(2-sulfoethyl) cyclohexane, 1,2-diol from 4-vinylcyclohexane-1,2-diol | INVISTA NORTH AMERICA S.A.R.L. | 2004-09-30 | — | — | US | disclosed |
| US-20040192976-A1 | Process for hydrolyzing water-insoluble epoxides | INVISTA NORTH AMERICA S.A.R.L. (F/K/A ARTEVA NORTH AMERICA S.A.R.L.) | 2004-09-30 | — | — | US | disclosed |
| CN-1219953-A | Fabric softening compound/composition | PROCTER & GAMBLE (US) | 1999-06-16 | — | — | CN | disclosed |
| CN-1196082-A | Concentrated stable fabric softening compositions comprising chelants | PROCTER & GAMBLE (US) | 1998-10-14 | — | — | CN | disclosed |
| US-5747443-A | BIODEGRADABLE QUATERNARY AMMONIUM COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 1998-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040192976-A1 | Process for hydrolyzing water-insoluble epoxides | EPHX2, ADH1C, HPD | ALDH1A1 717/4885ALOX15 157/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.